FDA Inspection
Hikma Pharmaceuticals USA INC.Hikma Pharmaceuticals USA INC. – FDA Inspection, Sep 19, 2017
Record Details
This FDA Inspection record concerns Hikma Pharmaceuticals USA INC., with an inspection on September 19, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · b413184b-50e8-42c5-a73c-43cfbf22c1c8
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1028066
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Hikma Pharmaceuticals USA INC.
27| Date | Classification | Office | Project area |
|---|---|---|---|
| September 18, 2026 | Not classified | Cincinnati District Office | |
| April 30, 2026 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 17, 2025 | Not classified | Cincinnati District Office | |
| July 23, 2024 | NAI | Compliance: Devices | |
| September 15, 2022 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Hikma Pharmaceuticals USA INC.
- FDA Inspection 1285748 - 2026-09-18
- FDA Inspection 1303412 - 2026-04-30
- FDA Inspection 1238509 - 2025-01-17
- FDA Inspection 1243797 - 2024-07-23
- FDA Inspection 1182363 - 2022-09-15
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.